Literature DB >> 9324302

Rapid amplification of cDNA ends (RACE) improves the PCR-based isolation of immunoglobulin variable region genes from murine and human lymphoma cells and cell lines.

A Doenecke1, E L Winnacker, M Hallek.   

Abstract

The isolation of rearranged immunoglobulin (Ig) variable region (V) genes is usually performed by PCR with consensus primers binding to conserved regions within the V sequences. However, the isolation of Ig genes by this method is hampered in 15-35% by technical difficulties, mostly mismatches of oligonucleotide primers to V sequences. In order to obtain DNA sequences from V heavy chain (VH) genes which could not be amplified with consensus primers, we used a modified PCR technique, the rapid amplification of cDNA ends (RACE) PCR in combination with new heavy chain constant region primers for the isolation of human and murine VH genes. In comparison, consensus primer PCR with different sets of previously published oligonucleotide primers was used. Both methods were applied to isolate VH genes from murine B cell lymphoma (A20 and BCL1), myeloma (NS1) and hybridoma (SP6) cell lines and from freshly isolated human chronic lymphocytic leukemia and lymphoma cells. RACE PCR allowed the amplification and subsequent cloning of the complete VH gene in all cases. In contrast, consensus primer PCR failed to isolate the VH sequence of the murine A20 cell line; this was explained by a mismatch of consensus primers with VH sequences. When both PCR methods amplified VH sequences, the DNA sequences obtained were identical. Taken together, RACE PCR represents a reliable and versatile method for the isolation of VH genes from human and murine lymphoma cells, in particular if consensus primer PCR fails.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9324302     DOI: 10.1038/sj.leu.2400781

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  14 in total

1.  Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation.

Authors:  Caroline L Wilson; Dominic W Hine; Ariel Pradipta; Jeffrey P Pearson; Willem van Eden; John H Robinson; Andrew M Knight
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

2.  Production of a recombinant monoclonal antibody to Herpes Simplex Virus glycoprotein D for immunoaffinity purification of tagged proteins.

Authors:  Sara M O'Rourke; Bin Yu; Javier F Morales; Chelsea M Didinger; David L Alexander; Christopher Vollmers; Phillip W Berman
Journal:  J Immunol Methods       Date:  2018-11-28       Impact factor: 2.303

3.  Successful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen.

Authors:  Alena A Chekmasova; Thapi D Rao; Yan Nikhamin; Kay J Park; Douglas A Levine; David R Spriggs; Renier J Brentjens
Journal:  Clin Cancer Res       Date:  2010-07-13       Impact factor: 12.531

4.  Benchmarking of T cell receptor repertoire profiling methods reveals large systematic biases.

Authors:  Pierre Barennes; Valentin Quiniou; Mikhail Shugay; Evgeniy S Egorov; Alexey N Davydov; Dmitriy M Chudakov; Imran Uddin; Mazlina Ismail; Theres Oakes; Benny Chain; Anne Eugster; Karl Kashofer; Peter P Rainer; Samuel Darko; Amy Ransier; Daniel C Douek; David Klatzmann; Encarnita Mariotti-Ferrandiz
Journal:  Nat Biotechnol       Date:  2020-09-07       Impact factor: 54.908

5.  Comparison of adenoviruses as oncolytics and cancer vaccines in an immunocompetent B cell lymphoma model.

Authors:  Eric A Weaver; Christopher Y Chen; Shannon M May; Mary E Barry; Michael A Barry
Journal:  Hum Gene Ther       Date:  2011-09-06       Impact factor: 5.695

6.  Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells.

Authors:  Max Warncke; Maike Buchner; Gudrun Thaller; Anna Dodero; Alla Bulashevska; Dietmar Pfeifer; Jens Timmer; Hendrik Veelken
Journal:  Cancer Immunol Immunother       Date:  2010-09-17       Impact factor: 6.968

7.  Target-selective homologous recombination cloning for high-throughput generation of monoclonal antibodies from single plasma cells.

Authors:  Nobuyuki Kurosawa; Megumi Yoshioka; Masaharu Isobe
Journal:  BMC Biotechnol       Date:  2011-04-13       Impact factor: 2.563

8.  Degenerated primer design to amplify the heavy chain variable region from immunoglobulin cDNA.

Authors:  Ying Wang; Wei Chen; Xu Li; Bing Cheng
Journal:  BMC Bioinformatics       Date:  2006-12-12       Impact factor: 3.169

9.  The INNs and outs of antibody nonproprietary names.

Authors:  Tim D Jones; Paul J Carter; Andreas Plückthun; Max Vásquez; Robert G E Holgate; Isidro Hötzel; Andrew G Popplewell; Paul W H I Parren; Markus Enzelberger; Hendrik J Rademaker; Michael R Clark; David C Lowe; Bassil I Dahiyat; Victoria Smith; John M Lambert; Herren Wu; Mary Reilly; John S Haurum; Stefan Dübel; James S Huston; Thomas Schirrmann; Richard A J Janssen; Martin Steegmaier; Jane A Gross; Andrew R M Bradbury; Dennis R Burton; Dimiter S Dimitrov; Kerry A Chester; Martin J Glennie; Julian Davies; Adam Walker; Steve Martin; John McCafferty; Matthew P Baker
Journal:  MAbs       Date:  2016       Impact factor: 5.857

10.  Identification of Immunoglobulin Gene Sequences from a Small Read Number of mRNA-Seq Using Hybridomas.

Authors:  Yuki Kuniyoshi; Kazumitsu Maehara; Takeshi Iwasaki; Masayasu Hayashi; Yuichiro Semba; Masatoshi Fujita; Yuko Sato; Hiroshi Kimura; Akihito Harada; Yasuyuki Ohkawa
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.